Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Prof. Nicolas Barry-Delongchamps, Professor of Urology at Cochin Hospital and Principal Investigator of the VIOLETTE trial, will present the final results and one-year patients follow-up from the ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Prostate Cancer Survivor, Jerry McCormick, urges Black men 45 years and older to get screened as soon as possible, because early detection could save their life.

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

The UCSF Helen Diller Family Comprehensive Cancer Center announced today that the UCSF Prostate Cancer Program is the recipient of the National Cancer Institute’s (NCI) Specialized Programs of ...